News
The drug is Ambroxol. It’s been used for decades to treat respiratory ailments by thinning mucus and easing coughs. But now, ...
Researchers at Northwestern Medicine have discovered that a virus that has flown under the radar for years might be a potential contributor to the neurodegenerative disorder.
Parkinson's disease is best treated when detected early, but the cost of those tests makes that difficult. A new, 3D-printed ...
A decades-old cough medicine, Ambroxol, could be on the verge of a dramatic second act—not for sore throats, but for ...
5h
GB News on MSNParkinson's breakthrough as 3 key 'behavioural changes' may predict disease before symptoms appearScientists in China have identified specific physical behaviours that could provide early warning signs for Parkinson's ...
In those nations, MAID is available to a wider universe of pained people, not just those with fewer than six months to live.
6h
InvestorsHub on MSNNiagen Bioscience Shares Climb Following Exclusive License for Parkinson’s TherapyNiagen Bioscience Inc. (NASDAQ:NAGE) saw its stock rise 2% after securing an exclusive global commercial license from Norway’s Haukeland University Hospital to develop its nicotinamide riboside ...
A neglected piece of the Alzheimer's puzzle has been getting increased scientific attention: why women are twice as likely as ...
Because Alzheimer’s is just one of several diseases that cause dementia, the key distinction lies in their scope.
A new drug originally developed to treat a different brain disease is now showing signs that it could help people with ...
Parkinson’s Disease Support Group: 2 p.m. meeting at Sanford Health WindSong in Bemidji, open to anyone with Parkinson’s ...
New research shows that inhibiting overactive LRRK2 enzymes could stabilize Parkinson's disease progression, with Stanford ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results